Pritesh Shah, MD
Geriatric Psychiatry · Westwood, NJNPI 1114121175
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 299 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 27.9% of the total. Among geriatric psychiatry clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 299 payments — averaging $15.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$513
- Alkermes, Inc.$399
- Neurocrine Biosciences, Inc.$314
- Lundbeck LLC$282
- Takeda Pharmaceuticals U.S.A., Inc.$268
- plus $2K from 21 others
What the payments were for
- Food & beverage$4,48598%
- Education$742%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 108 | $1,270 |
| Otsuka America Pharmaceutical, Inc. | 26 | $513 |
| Alkermes, Inc. | 27 | $399 |
| Neurocrine Biosciences, Inc. | 14 | $314 |
| Lundbeck LLC | 19 | $282 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $268 |
| Teva Pharmaceuticals USA, Inc. | 13 | $200 |
| Almatica Pharma LLC | 11 | $158 |
| Neos Therapeutics, LP | 9 | $152 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $140 |
| AstraZeneca | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 8 | $121 |
| Sunovion Pharmaceuticals Inc. | 9 | $112 |
| E.r. Squibb & Sons, L.L.C. | 6 | $93 |
| Bausch Health US, LLC | 4 | $91 |
| Axsome Therapeutics, Inc. | 4 | $81 |
| Jazz Pharmaceuticals Inc. | 3 | $41 |
| Tris Pharma Inc | 2 | $37 |
| Johnson & Johnson | 2 | $28 |
| Neuronetics, Inc. | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $19 |
| Eisai Inc. | 1 | $18 |
| Corium, LLC | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| Indivior Inc. | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Shire North American Group Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEZSPIRE$125
- ABILIFY MAINTENA$118
- INGREZZA$113
How this compares
$4,559 in reported general payments places this provider in the 95th percentile of 26 geriatric psychiatry providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 46 | $73,780 |
| TrintellixVortioxetine Hydrobromide | 47 | $39,753 |
| ZyprexaOlanzapine | 24 | $25,298 |
| Aripiprazole | 133 | $18,889 |
| XanaxAlprazolam | 15 | $9,212 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 16 | $7,343 |
| Vilazodone Hcl | 43 | $4,598 |
| Bupropion XlBupropion Hcl | 149 | $3,598 |
| Escitalopram Oxalate | 280 | $3,540 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 52 | $3,400 |
| Mirtazapine | 83 | $3,378 |
| Fluoxetine Hcl | 85 | $3,130 |
| Divalproex Sodium | 55 | $2,437 |
| Divalproex Sodium ErDivalproex Sodium | 34 | $2,383 |
| Quetiapine Fumarate | 43 | $1,535 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $1,270 | $73,78046 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $268 | $39,75347 claims |
| Almatica Pharma LLCSertraline Hcl | $158 | $1,156101 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 26 geriatric psychiatry providers in New Jersey.
Other geriatric psychiatry in Westwood
- Lina ShihabuddinNewark$2K
- Shailaja ShahHillsborough$1K
- Gina WilberHowell$1K
- Vanajakshi PaturuFair Lawn$1K
- Sheema ImranPerth Amboy$853
- Syed RazaBrick$843
- Pooja TandonToms River$781
- Ajanta VinekarPlainsboro$631
- Marc RothmanWestmont$504
- Matthew BarnasCedar Knolls$493
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.